Breaking News

Givaudan Will Buy Back

November 14, 2005

Givaudan AG, Geneva, Switzerland, said it plans to buy back 10% of its own shares, citing a lack of acquisition prospects as the reason.
Givaudan’s board of directors plans to start a new share buy-back program of up to 800,000 registered shares, or 10% of the share capital. A further reduction of the share capital by the amount of shares to be repurchased will be proposed at the company’s annual general meeting April 16, 2004, to further improve earnings per share, company executives said.
The buy-back program was motivated by the company’s ample liquid funds, high free cash flow, attractive share price and a current lack of major value-adding acquisitions. On March 31, the company completed its first share buy-back program, according to a company spokesperson.

blog comments powered by Disqus
  • Senior Skin Care

    Senior Skin Care

    Christine Esposito, Associate Editor||July 19, 2016
    McCord Research and Product Quest Manufacturing roll out new hospital-grade skin care kits for seniors to use at home.

  • Naterra Expands Tree Hut Range

    Naterra Expands Tree Hut Range

    Melissa Meisel, Associate Editor||July 18, 2016
    New ‘Bare’ collection is out now.

  • An Antioxidant Arsenal

    An Antioxidant Arsenal

    July 11, 2016
    BioRewind is Dermarché Labs' new anti-aging regimen that delivers broad-spectrum antioxidant protection against free radicals

  • Sustainability is Omnipresent

    Sustainability is Omnipresent

    Christine Esposito , Associate Editor||July 1, 2016
    Industry stakeholders convene in New York City for Organic Monitor’s annual event

  • Perceived Perfection

    Perceived Perfection

    Christine Esposito, Associate Editor||July 1, 2016
    From primers to pressed powders, facial cosmetics help create the illusion of a flawless complexion.

  • Preserve & Serve

    Preserve & Serve

    Melissa Meisel , Associate Editor||July 1, 2016
    Suppliers with innovative preservatives provide staying power for formulations.